(Q44667833)

5 December 2017

title

The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma (English)

1 reference

5 December 2017

Chengying Jiang

1

1 reference

5 December 2017

Fangke Hu

2

1 reference

5 December 2017

Yanhong Tai

3

1 reference

5 December 2017

Jingli Du

4

1 reference

5 December 2017

Beibei Mao

5

1 reference

5 December 2017

Zengqiang Yuan

6

1 reference

5 December 2017

Yan Wang

7

1 reference

5 December 2017

Lixin Wei

8

1 reference

5 December 2017

publication date

7 January 2012

1 reference

Journal of Cancer Research and Clinical Oncology

5 December 2017

published in

1 reference

5 December 2017

volume

138

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

637-646

1 reference

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

The tyrosine phosphatase Shp2 (PTPN11) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Protein-tyrosine phosphatases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1143-5

Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22228034

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-011-1143-5

1 reference

5 December 2017

1 reference